Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial

˜The œLancet. Gastroenterology & hepatology 2026

View at publisher
Authors: Walter Reinisch, David Stepek, Radosław Kempiński, Silvio Danese, Bruce E Sands, Bogdan Ratiu-Duma, Rajendra Singh, Phillip Levine, Hadas Barkay, Nicholas Gross, Ken Abrams, Vipul Jairath
DOI: 10.1016/s2468-1253(26)00120-2
Cited by: 4
References: 28

Fields of Study & Subjects

Inflammatory Bowel Disease Drug Transport and Resistance Mechanisms Inflammatory mediators and NSAID effects

Publication details

Journal / source
˜The œLancet. Gastroenterology & hepatology
Publisher
Elsevier BV
Volume
11
Issue
9
Pages
775–785
Publication date
16 July 2026
Language
EN